Sid O’Bryant Ph.D. to Present Seminar Entitled “Examining Biomarkers of Alzheimer’s Disease Across Diverse Populations” as a part of NTERI Interdisciplinary Seminar Series (ISS)

We are pleased to announce that Sid O’Bryant, Ph.D., will be presenting a seminar entitled ” Examining Biomarkers of Alzheimer’s Disease Across Diverse Populations” as part of the North Texas Research Institute (NTERI) Interdisciplinary Seminar Series (ISS).

Date: Thursday, December 7, 2023
Time: 12:00 PM – 1:00 PM
Location: EAD 514

Dr. Sid O’Bryant is a Professor at the Department of Family Medicine and Osteopathic Manipulative Medicine and an Executive Director of the Institute for Translational Research at the Texas College of Osteopathic Medicine.

Dr. O’Bryant’s research is dedicated to the advancement of precision medicine within the realm of neurodegenerative disorders. This encompasses a wide spectrum of conditions such as Alzheimer’s disease, Down syndrome, Lewy Body disease, Parkinson’s disease, and traumatic brain injury. The focus is on tailoring medical treatment to the individual characteristics of each patient, thereby enhancing the efficacy and outcomes of therapeutic interventions for these complex diseases.

Dr. O’Bryant’s research, supported by multiple NIH grants, is centered on innovative methods for early disease detection, efficient screening for clinical trials, both therapeutic and preventative and tailored patient stratification to enhance treatment efficacy.

A significant aspect of the lab’s work is examining the effects of ethnicity and diversity on cognitive decline during aging. This is exemplified by the Health & Aging Brain among Latino Elders (HABLE) study, which is spearheaded by the lab. HABLE is the most comprehensive study of Mexican-American brain aging to date.

For more information, click here:

NTERI Interdisciplinary Seminar Series (ISS)